Market Research Logo

Global Contrast Injector Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

Global Contrast Injector Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

The global contrast injector market is expected to grow with the CAGR of approximately 7.5% during the forecast period (2016-2023). The factors that are supporting to drive the growth of contrast injector market are increasing prevalence of chronic diseases across the globe; increasing number of approvals for contrast agents, increasing demand for imaging procedures such as MRI, CT etc. and increasing adoption of contrast media injectors by physicians. Contrast media injectors offer features i.e. pre-loaded protocols and safety to avoid extravasations and support physicians during contrast media insertion. It also enables physicians for early diagnosis of chronic diseases such as cardiac and neurological disorders. Therefore, physicians are highly shifting towards contrast injector for better imaging and technological innovations are also further increasing the effectiveness of contrast injectors. For example: In March 2015, Bracco introduced the “Empower CTA+”, a touch-screen based contrast injector system for CT angiography. This allows end-users to totally modify the injection experience for every patient by simultaneous variable flow rates, saline jump and saline advance; saline advance enables the technologist to examine the patient’s patency and vein integrity while saline jump supports to minimize contrast dose through enabling immediate innovation to saline, once pacification has been touched. Thus, such kind of technological innovations in contrast agents supports physicians in better diagnosis.

On the basis of geography, North America occupied major share in 2016 due to increasing prevalence of chronic diseases in the region as well as high advancements in healthcare sector in the region. However, Europe has also attributed for the high demand of contrast media injectors (CMI) among radiology procedures by clinicians and hospitals. Asia Pacific is also expected to witness high growth as the demand for contrast injector is increasing in China & India along with increasing adoption of imaging modalities in hospitals and diagnostic centers. Increasing healthcare expenditure in China & India as well as medical tourism enables the demand for better solutions to diagnose disease which further propels the demand for contrast injector. The major players included in the report are as GE Healthcare (Germany), Vivid Imaging (U.S.), Medtron AG (Germany), Bayer AG (Germany) etc. Mergers & acquisitions, product launches, expansion etc. are the key strategies adopted by the major players to increase market share and gain competitive advantage.

The global contrast injector market is segmented on the basis of product and end-user. The product segment is further classified into CT Injectors, MRI Injectors, Cardiology Injectors and Angiography Injectors. The end-user segment is further classified into ambulatory surgical centers, hospitals and diagnostics centers.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL CONTRAST INJECTOR MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS
2.8.3. TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. INCREASING PREVALENCE OF CHRONIC DISEASES ACROSS THE GLOBE
3.1.2. INCREASING NUMBER OF APPROVALS FOR CONTRAST AGENTS
3.1.3. INCREASING ADOPTION OF CONTRAST MEDIA INJECTORS BY PHYSICIANS
3.1.4. INCREASING DEMAND FOR IMAGING PROCEDURES SUCH AS MRI, CT SCAN ETC.
3.2. MARKET RESTRAINTS
3.2.1. HIGH COST ASSOCIATED WITH THE CONTRAST MEDIA INJECTORS
3.2.2. HARMFUL EFFECTS OF CONTRAST AGENTS
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASING DEMAND IN DEVELOPING COUNTRIES
3.3.2. ADVANCES IN CONTRAST MEDIA INJECTORS
3.4. MARKET CHALLENGES
3.4.1. LACK OF SKILLED PROFESSIONALS
3.4.2. HIGH INITIAL INVESTMENT
4. MARKET SEGMENTATION
4.1. GLOBAL CONTRAST INJECTOR MARKET BY PRODUCT
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL CT INJECTORS MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL MRI INJECTORS MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL CARDIOLOGY INJECTORS MARKET
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.3.4. KEY CONCLUSIONS
4.1.5.4. GLOBAL ANGIOGRAPHY INJECTORS MARKET
4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.2. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.4.4. KEY CONCLUSIONS
4.2. GLOBAL CONTRAST INJECTOR MARKET BY END-USER
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL CONTRAST INJECTOR MARKET IN AMBULATORY SURGICAL CENTERS
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL CONTRAST INJECTOR MARKET IN HOSPITALS
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.4. KEY CONCLUSIONS
4.2.5.3. GLOBAL CONTRAST INJECTOR MARKET IN DIAGNOSTIC CENTERS
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.4. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITIONS
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
5.2. TOP 10 COMPANY ANALYSIS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL CONTRAST INJECTOR MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRIAL ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATION AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. ANGIODYNAMICS, INC. (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. APOLLO RT CO., LTD. (HONG KONG)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.2.6. STRATEGIC ANALYSIS
7.3. ARGON MEDICAL DEVICES, INC. (U.S.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS
7.4. BAYER AG (GERMANY)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. BRACCO IMAGING S.P.A. (ITALY)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.5.6. STRATEGIC ANALYSIS
7.6. GE HEALTHCARE (UK)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.6.6. STRATEGIC ANALYSIS
7.7. GUARBET GROUP (FRANCE)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.7.6. STRATEGIC ANALYSIS
7.8. IVES HEALTHCARE PVT LTD (INDIA)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.8.6. STRATEGIC ANALYSIS
7.9. MALLINCKRODT PHARMACEUTICALS (UK)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.9.6. STRATEGIC ANALYSIS
7.10. MEDTRON AG (GERMANY)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11. NEMOTO KYORINDO CO., LTD. (JAPAN)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. PRECISE BIOMEDICAL, INC (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. SINO MEDICAL-DEVICE TECHNOLOGY CO. LTD. (CHINA)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. ULRICH GMBH & CO. KG (GERMANY)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. VIVID IMAGING (U.S.)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL CONTRAST INJECTOR MARKET BY PRODUCT ($ MILLION)
GLOBAL CT INJECTORS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL MRI INJECTORS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL CARDIOLOGY INJECTORS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL ANGIOGRAPHY INJECTORS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL CONTRAST INJECTOR MARKET BY END-USER ($ MILLION)
GLOBAL CONTRAST INJECTOR MARKET IN AMBULATORY SURGICAL CENTERS BY GEOGRAPHY ($ MILLION)
GLOBAL CONTRAST INJECTOR MARKET IN HOSPITALS BY GEOGRAPHY ($ MILLION)
GLOBAL CONTRAST INJECTOR MARKET IN DIAGNOSTICS CENTERS BY GEOGRAPHY ($ MILLION)
NORTH AMERICA CONTRAST INJECTOR MARKET ($ MILLION)
EUROPE CONTRAST INJECTOR MARKET ($ MILLION)
ASIA PACIFIC CONTRAST INJECTOR MARKET ($ MILLION)
REST OF THE WORLD CONTRAST INJECTOR MARKET ($ MILLION)
LIST OF FIGURES
GLOBAL CONTRAST INJECTOR MARKET BY CT INJECTORS ($ MILLION)
GLOBAL CONTRAST INJECTOR MARKET BY MRI INJECTORS ($ MILLION)
GLOBAL CONTRAST INJECTOR MARKET BY CARDIOLOGY INJECTORS ($ MILLION)
GLOBAL CONTRAST INJECTOR MARKET BY ANGIOGRAPHY INJECTORS ($ MILLION)
GLOBAL CONTRAST INJECTOR MARKET BY AMBULATORY SURGICAL CENTERS ($ MILLION)
GLOBAL CONTRAST INJECTOR MARKET BY HOSPITALS ($ MILLION)
GLOBAL CONTRAST INJECTOR MARKET BY DIAGNOSTICS CENTERS ($ MILLION)
UNITED STATES (U.S.) CONTRAST INJECTOR MARKET ($ MILLION)
CANADA CONTRAST INJECTOR MARKET ($ MILLION)
UNITED KINGDOM (UK) CONTRAST INJECTOR MARKET ($ MILLION)
FRANCE CONTRAST INJECTOR MARKET ($ MILLION)
GERMANY CONTRAST INJECTOR MARKET ($ MILLION)
SPAIN CONTRAST INJECTOR MARKET ($ MILLION)
ROE CONTRAST INJECTOR MARKET ($ MILLION)
INDIA CONTRAST INJECTOR MARKET ($ MILLION)
CHINA CONTRAST INJECTOR MARKET ($ MILLION)
JAPAN CONTRAST INJECTOR MARKET ($ MILLION)
AUSTRALIA CONTRAST INJECTOR MARKET ($ MILLION)
ROAPAC CONTRAST INJECTOR MARKET ($ MILLION)
LATIN AMERICA CONTRAST INJECTOR MARKET ($ MILLION)
MENA CONTRAST INJECTOR MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report